These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
99 related items for PubMed ID: 1328946
1. Pathogenesis of severe hyperoxalaemia in Crohn's disease-related renal failure on maintenance haemodialysis: successful management with pyridoxine. Marangella M, Vitale C, Petrarulo M, Cosseddu D, Gallo L, Linari F. Nephrol Dial Transplant; 1992; 7(9):960-4. PubMed ID: 1328946 [No Abstract] [Full Text] [Related]
2. Reduction of elevated plasma oxalic acid by pyridoxine therapy in patients on RDT. Balcke P, Schmidt P, Zazgornik J, Kopsa H. Proc Eur Dial Transplant Assoc; 1983; 19():308-12. PubMed ID: 6878246 [Abstract] [Full Text] [Related]
3. Effect of pyridoxine supplementation on plasma oxalate concentrations in patients receiving dialysis. Tomson CR, Channon SM, Parkinson IS, Sheldon WS, Ward MK, Laker MK. Eur J Clin Invest; 1989 Apr; 19(2):201-5. PubMed ID: 2499479 [Abstract] [Full Text] [Related]
4. Oxalate-induced acute renal failure in Crohn's disease. Mandell I, Krauss E, Millan JC. Am J Med; 1980 Oct; 69(4):628-32. PubMed ID: 7424952 [Abstract] [Full Text] [Related]
6. Cadaveric renal transplantation in a patient with primary hyperoxaluria. A case report. Bohannon LL, Norman DJ, Barry J, Bennett WM. Transplantation; 1983 Jul; 36(1):114-5. PubMed ID: 6346609 [No Abstract] [Full Text] [Related]
7. [Oxalic acid metabolism in chronic renal failure]. Balcke P. Wien Klin Wochenschr Suppl; 1985 Jul; 160():1-15. PubMed ID: 3859955 [Abstract] [Full Text] [Related]
8. Effect of vitamin B6 administration on elevated plasma oxalic acid levels in haemodialysed patients. Balcke P, Schmidt P, Zazgornik J, Kopsa H, Deutsch E. Eur J Clin Invest; 1982 Dec; 12(6):481-3. PubMed ID: 6818036 [Abstract] [Full Text] [Related]
9. Successful strategies for renal transplantation in primary oxalosis. Scheinman JI, Najarian JS, Mauer SM. Kidney Int; 1984 May; 25(5):804-11. PubMed ID: 6381856 [Abstract] [Full Text] [Related]
13. Oxalate metabolism in end-stage renal disease: the effect of ascorbic acid and pyridoxine. Morgan SH, Maher ER, Purkiss P, Watts RW, Curtis JR. Nephrol Dial Transplant; 1988 Aug; 3(1):28-32. PubMed ID: 3132636 [Abstract] [Full Text] [Related]
14. Crohn's disease and secondary amyloidosis: early complication? A case report and review of the literature. Basturk T, Ozagari A, Ozturk T, Kusaslan R, Unsal A. J Ren Care; 2009 Sep; 35(3):147-50. PubMed ID: 19689697 [Abstract] [Full Text] [Related]
15. Pathophysiology and management of some medical complications of Crohn's disease. Turnberg LA. Ann R Coll Surg Engl; 1982 Mar; 64(2):105-7. PubMed ID: 7065595 [Abstract] [Full Text] [Related]